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In Brief Pusapati et al. use CRISPR-based screens in mammalian cells to identify genes that modify cellular responses to Hedgehog morphogens. The screens provide a comprehensive view of the regulatory structure of Hedgehog signaling, highlight its intimate connection to primary cilia and ciliopathies, and uncover a role for Smoothened trafficking in regulating signaling strength.
INTRODUCTION
The Hedgehog (Hh) signaling pathway is a system for cell-cell communication that coordinates multiple processes during animal development. A hallmark of Hh ligands is their function as morphogens, secreted factors that pattern tissues as diverse as the Drosophila wing disc and the vertebrate spinal cord. The mechanism by which Hh ligands inscribe a pattern on a population of precursor cells is based on their ability to guide the adoption of distinct cell fates in response to different levels of signaling. For example, in the vertebrate neural tube, a temporal and spatial gradient of the ligand Sonic Hedgehog (SHH) drives the patterning of spinal neural progenitor subtypes along the dorsal-ventral axis (Dessaud et al., 2008) .
Genetics has played a central role in the discovery and mechanistic understanding of Hh signaling. Both the identities and regulatory relationships between many of the protein components in the Hh pathway were elucidated initially through genetic analyses in Drosophila (N€ usslein-Volhard and Wieschaus, 1980) . Two decades later, forward genetic screens in the mouse led to the surprising discovery that vertebrate (but not Drosophila) Hh signaling depends on primary cilia, solitary membrane-enveloped projections present on the surfaces of most cells (Huangfu et al., 2003) . These specialized organelles function as signaling centers during development in many tissues, demonstrated by the discovery of an ever-expanding class of human genetic disorders called ciliopathies (Reiter and Leroux, 2017) . Many of the phenotypes seen in patients with ciliopathies are consistent with abnormalities in Hh signaling (Bangs and Anderson, 2016) . Thus, genetic screens performed in different systems and under a variety of conditions can uncover unexpected layers of regulation in signaling pathways.
Recent methodological advances using CRISPR/Cas9-based methods or haploid human cells have facilitated the application of genome-wide, loss-of-function screens to probe signaling pathways in cultured cells (Lebensohn et al., 2016; Parnas et al., 2015) . We systematically screened for positive, negative, and attenuating regulators of Hh signal reception using a fluorescence-based transcriptional reporter for phenotypic enrichment. In a set of four genome-wide screens, we identified most of the core, non-redundant components of vertebrate Hh signaling. Consistent with the body of work from human and mouse genetics, these screens confirmed the importance of cilia in Hh signaling, detecting $20% of known cilia genes and $30% of known ciliopathy genes as having a significant effect on Hh signaling. Our screens for negative and attenuating regulators uncovered a role for membrane trafficking events in modifying target cell responses to Hh ligands. Loss-of-function mutations in three of the principal hits sensitized cultured fibroblasts and neural progenitor cells to SHH, shifting the SHH dose-response curve and altering the relationship between the concentration of SHH and target cell fate. The combined results of these screens provide a comprehensive view of the regulatory structure of Hh signaling and its intimate connection to primary cilia and ciliopathies.
RESULTS

Genetic Screens in Mouse Fibroblasts to Identify Regulators of the Hh Pathway
We constructed and characterized a clonal NIH/3T3 cell line, hereafter called NIH/3T3-CG, that expressed (1) Cas9 and (2) GFP driven by a Hh-responsive promoter element containing eight binding sites for the GLI family of Hh transcription factors (GLI-GFP reporter) ( Figure S1A ). GFP fluorescence in NIH/3T3-CG cells increased in response to SHH in a dose-dependent, saturable fashion ( Figure S1B ). For the screens and the followup experiments described in this study, we left cells untreated (hereafter labeled ''NoSHH''), exposed them to a low, sub-saturating concentration of SHH (''LoSHH'') that increased reporter activity to <10% of maximum, or exposed them to a high, near-saturating concentration of SHH (''HiSHH'') that increased reporter activity to >95% of maximum ( Figure S1B ). Compared with non-targeting controls, single guide RNAs (sgRNAs) targeting the positive regulators Smoothened (Smo) and G-protein-coupled receptor kinase 2 (Adbrk1 or Grk2) reduced SHH-induced GFP fluorescence and sgRNAs targeting the negative regulators Patched 1 (Ptch1) and Suppressor of Fused (Sufu) induced a SHH-independent increase in GFP fluorescence ( Figure S1C ). These results show that GFP fluorescence in NIH/ 3T3-CG cells provided a quantitative readout of Hh signaling with a dynamic range that was sensitive to the perturbation of both positive and negative regulators and consequently could be used for a genome-wide pooled screen based on cell sorting.
We conducted four genome-wide screens in NIH/3T3-CG cells, each in duplicate, for a total of eight independent screens using the lentivirus-based Brie library ( Figure 1A ) (Doench et al., 2016) . In the screen for positive regulators (hereafter referred to as the ''HiSHH_Bot10%'' screen), we treated NIH/3T3-CG cells with HiSHH and then isolated $2 million with the lowest 10% of GFP fluorescence by fluorescence-activated cell sorting (FACS) ( Figure 1B ). In the three screens for negative regulators and attenuators, we isolated $1 million cells with the highest 5% of GFP fluorescence after treatment with HiSHH (the ''HiSHH_Top5%'' screen), LoSHH (the ''LowSHH_Top5%'' screen), or NoSHH (the ''NoSHH_Top5%'' screen) ( Figures  1C-1E ). For each screen, sgRNA enrichment and depletion in the selected population was compared with the corresponding unsorted control population across two independent replicates using the MAGeCK algorithm .
Screens Identified Most Known Regulators of Hh Signaling and Many Genes Linked to Cilia and Ciliopathies
The results of the screens were visualized using volcano plots (Figures 1B-1E ; complete tabulated results provided in Table  S1 ). The asymmetric nature of the plots showed that the statistical power to detect depletion in the sorted population was lower than the power to detect enrichment. Hence, all further analyses only considered genes that were significant based on their false discovery rate (FDR)-corrected p values for enrichment in the sorted population.
Taken together, the screens identified a majority of the components at all levels of Hh signaling from the cell surface to the nucleus (see Figure 2A for a comprehensive summary and Table  S2 for a manually curated list of Hh genes). A top hit in all three negative regulator screens was the main receptor for SHH, PTCH1 ( Figures 1C-1E ). In the absence of Hh ligands, PTCH1 blocks the activity of the G-protein-coupled receptor (GPCR)-family protein SMO, which transmits the Hh signal across the membrane. As expected, SMO was a top hit in the positive regulator screen, along with genes encoding several proteins that have been previously implicated in SMO signaling, including GRK2 and the SMO-interacting proteins EVC, IQCE, and LZTFL1 ( Figures 1B and 2A) .
SMO antagonizes the effects of two major cytoplasmic negative regulators: Suppressor of Fused (SUFU) and Protein Kinase A (PKA) (Figure 2A ). SUFU and PKA promote the proteolytic conversion of GLI3 into a transcriptional repressor (GLI3R) and also block the formation of the transcriptional activators GLI2A and GLI3A. SUFU was a top hit in all negative regulator screens ( Figures 1C-1E ). PKA was not identified, likely because its catalytic subunit can be encoded by two redundant genes (Prkaca and Prkacb). However, several proteins that regulate PKA activity and have previously been implicated in Hh signaling were prominent screen hits (Figure 2A ). Two proteins that increase PKA activity and so function as negative regulators of Hh signaling, adenylate cyclase (ADCY6) and its activating heterotrimeric G-protein subunit Ga S (the product of Gnas gene), were identified in the negative regulator screens. Conversely, Ga i3 (the product of Gnai3 gene), a heterotrimeric G-protein subunit that inhibits adenylate cyclases and reduces PKA activity, was identified as a positive regulator (Figure 2A ). GPR161, a Ga S -coupled negative regulator of Hh signaling, was not targeted by the Brie library, but TULP3 and GRK2, implicated as positive and negative regulators of GPR161 function respectively, were identified in screens for attenuating regulators (LoSHH_Top5%) and positive regulators (HiSHH_Bot10%), respectively.
At the level of the Hh-responsive transcription factors (TFs), our screens for negative regulators identified proteins (GSK3b, FBWX11, KIF7, and RAB23) that promote the biogenesis of GLI3R and proteins (MED12 and BCOR) that promote the transcriptional repression of Hh target genes ( Figure 2A) . Conversely, the HiSHH_Bot10% screen for positive regulators identified components (DYRK1A, BRD2, and PRMT1) that promote activation of Hh target genes ( Figure 2A ). Taken together, these results demonstrated that our screening strategy based on cell sorting could identify many non-redundant positive, negative, and attenuating regulators of Hh signaling.
To provide a more unbiased view of the functional classes of genes identified by our screens, we performed gene set analyses on the 641 genes across all four screens that were enriched in the sorted populations with an FDR-corrected p value <0.1 (Table S1 ). With this list as the input, Gene Ontology (GO) analysis identified ''cilium morphogenesis'' as the most enriched term (FDR-corrected p value $10 À19 ). Strikingly, nearly all of (B-E) Volcano plots from the four screens. For each gene, the x axis shows its enrichment or depletion, calculated as the mean of all four sgRNAs targeting the gene, in the sorted population relative to the corresponding unsorted population, and the y axis shows statistical significance as measured by the false discovery rate (FDR)-corrected p value. The horizontal dashed line represents a p value threshold of 0.1. Positive and negative Hh pathway regulators are labeled as large teal and magenta dots, respectively; cilia genes as medium blue dots; all other genes as small gray dots. See also Figure S1 and Table S1 . (Pletscher-Frankild et al., 2015) . (C) Fractional enrichment of known Hh, cilia, and ciliopathy genes in all screens. (D) Cumulative distribution function of HiSHH_Bot10% screen ranks for 123 Hh genes, 407 cilia genes, 176 ciliopathy genes, and two control gene lists (237 MAPK genes from the KEGG database and a random set of 300 genes). Statistical significance was calculated based on the top 2,000 genes using the hypergeometric test. See also Table S2. the top disease associations found in this gene list were known ciliopathies or congenital anomalies associated with defects in cilia or Hh signaling ( Figure 2B ).
To evaluate the enrichment of cilia-related genes among our screen hits, we used three benchmark gene lists. The first was a manually curated list of 176 genes (hereafter referred to as the ''Hh genes'' list shown in Table S2 ), which included all genes linked to a Hh-related signaling defect or phenotype in the PubMed database. A large number of these Hh genes were cilia-related genes, since even subtle defects in cilia structure or function can impair Hh signal transduction (Bangs and Anderson, 2016) . We also compared the list of screen hits with two recently published lists of (1) all known ciliary genes (n = 426) and (2) all known ciliopathy genes (n = 186) that build on the gold-standard SYSCILIA compendium (Reiter and Leroux, 2017; van Dam et al., 2013) . Taken together, the four screens identified 40% of Hh genes, 20% of all cilia genes, and 30% of all ciliopathy genes as significant hits ( Figure 2C ). Most of the cilia-related genes were identified in the HiSHH_Bot10% screen for positive regulators or the NoSHH_Top5% screen (Figures 1B and 1E) . Cilia genes were hits in the NoSHH_Top5% screen because ciliary defects prevent the formation of GLI3R and thus lead to the transcriptional de-repression of some Hh target genes (Huangfu and Anderson, 2005) . A cumulative distribution function plot showed that the top 2,000 hits from the HiSHH_ Bot10% screen were highly enriched for cilia-and ciliopathyrelated genes from each of these three benchmark lists (Figure 2D ). Since cilia are essential for the transduction of high-level Hh signals, very few ciliary genes emerged as hits in the HiSHH_ Top5% and LoSHH_Top5% screens ( Figures 1C and 1D) .
Our results are consistent with studies from mouse and human genetics that indicate the close and complex relationship between Hh signaling and primary cilia at multiple levels of the pathway (Bangs and Anderson, 2016) . Over the past decade, these studies have found that the Hh pathway is exquisitely sensitive to even subtle changes in cilia structure or function. Conversely, abnormalities in Hh signaling, read-out through phenotypes in mice or humans, have served as sensitive indicators of ciliary defects (Huangfu et al., 2003) . CRISPR-based screens in cultured cells using fluorescent transcriptional reporters to select for cells with altered levels of Hh signaling can provide an orthogonal strategy for the functional identification of ciliary genes.
Validation of Candidate Genes in Two Different Cell Types
We used a multi-step strategy (summarized in Figure S2A ) to select genes likely to have the strongest and most general effects on Hh signaling from the list of top-ranked hits from all four screens. Of the 69 genes that were tested in pooled cell lines during phase I of our validation strategy, genes targeted by at least one high-quality guide that mapped to a unique position in the mouse genome and either (1) decreased GFP fluorescence by R 2-fold (for positive regulators) or (2) increased GFP fluorescence by R 1.5-fold (for negative regulators) were selected for phase II of analysis ( Figure S2 ). The five genes that encoded putative positive regulators were Cep350, Pdcl, Rab34, Fkbp10, and Tubd1 ( Figure S2B ). Candidate negative regulators included two genes linked to heterotaxy and congenital heart defects (Mgrn1 and Megf8), two genes linked to hereditary cavernous malformations (Ccm2 and Pdcd10), Mesdc1, and an unstudied open reading frame annotated as BC030336 in mouse and C16orf52 in humans ( Figures S2C-S2E ). We named this gene Atthog for Attenuator of Hedgehog.
For each of these 11 genes, we generated 2-3 independent clonal NIH/3T3 cell lines with loss-of-function mutations. To exclude off-target effects of genome editing, we used sgRNAs that were different from the Brie library guides used in the initial screens and the first phase of validation (sgRNA sequences, sites targeted by the sgRNAs within each gene, and gels showing successful editing are shown in Table S3 ). To exclude genes that only influenced the synthetic GLI-GFP reporter, we evaluated Hh signaling in these clonal cell lines by measuring the induction of Gli1, an endogenous direct Hh target gene commonly used to measure signaling strength. Among cell lines lacking the putative positive regulators, Rab34
, and Pdcl1 À/À NIH/3T3 cells showed the strongest defects in SHH-induced Gli1 expression ( Figure 3A ). Among cell lines lacking negative regulators, Atthog
, and Mgrn1 À/À NIH/3T3 cells showed constitutive, SHH-independent induction of Gli1 ( Figure 3B ). Interestingly, exposure of cells to LoSHH, which barely increased Gli1 transcription in wild-type (WT) cells, produced maximal induction of Gli1 in mutant cell lines, showing that loss of these genes sensitized cells to SHH ( Figure 3B ). Cultured spinal neural progenitor cells (NPCs) function as an excellent model system for studying Hh signaling. When NPCs are induced to differentiate, their adopted identity is a direct product of Hh signaling strength (Cohen et al., 2013; Gouti et al., 2014; Jessell, 2000) . To test if our top candidates modulated Hh signaling in this physiologically relevant cell system, we individually knocked out the ten genes in mouse embryonic stem cells (mESCs), differentiated these cells toward spinal NPCs, and then exposed them to varying SHH concentrations. To facilitate this analysis, we used a recently described mESC line stably carrying dual fluorescent Hh signaling reporters: a GLI-Venus synthetic transcriptional reporter, analogous to the GLI-GFP reporter used in NIH/3T3 cells, and an OLIG2-mKate reporter in which the far-red fluorescent protein mKate was fused to the C terminus of endogenous Olig2 via a self-cleaving peptide (https://doi.org/10.1101/104307). OLIG2-mKate fluorescence reports on the SHH-induced differentiation of mESCs into spinal motor neuron progenitors. mESCs harboring this dual Hh signaling reporter system were differentiated into NPCs and FACS was used to simultaneously measure SHH-induced increases in Venus ( Figure 3C ) and mKate ( Figure 3D ) fluorescence. As in NIH/3T3 cells, loss-offunction mutations in Rab34, Pdcl, and Tubd1 led to the strongest decreases in signaling. The loss of Mgrn1, Atthog, and Megf8 function had minimal effects on the basal levels of Venus and mKate fluorescence ( Figures 3C and 3D) In summary, data from clonal derivatives of two distinct cell types using both target gene expression assays and differentiation assays identified six genes for further analysis: the positive regulators Rab34, Tubd1, and Pdcl, and the negative regulators Mgrn1, Megf8, and Atthog.
Positive Regulators of Hh Signaling Are Required for Primary Cilia Functions Two assays were used to decipher how the six selected genes influenced Hh signaling. First, we used immunoblotting to measure protein levels of key Hh pathway components in clonal NIH/3T3 cell lines carrying loss-of-function mutations in each gene. GLI1 and PTCH1 are encoded by direct Hh target genes and so their abundance provides a transcriptional readout of signaling. GLI3R abundance provides a non-transcriptional readout for signaling, since its biogenesis is negatively regulated by Hh signals. Importantly, GLI3R levels in the absence of SHH report on the integrity of primary cilia: loss of cilia leads to a reduction in GLI3R and the consequent de-repression of some Hh target genes (Huangfu and Anderson, 2005) .
Second, we measured the dynamic, SHH-regulated localization of endogenous Hh pathway components at primary cilia by immunofluorescence (IF) (Briscoe and Thé rond, 2013) . In the absence of SHH, PTCH1 is concentrated in and around the ciliary membrane. SHH binding to PTCH1 leads to its clearance from the cilium and cell surface, allowing SMO to accumulate in the ciliary membrane and adopt an active conformation. SMO activation is correlated with increased accumulation of GLI2/3 at the tips of cilia. Trafficking of the SUFU-GLI2/3 complex through cilia is required for the conversion of GLI2 and GLI3 into potent transcriptional activators. Thus, ciliary levels of PTCH1, SMO, and GLI2 can be used to Figure S2 and Table S3. evaluate the status of signal propagation at multiple levels in the pathway ( Figure 4A ).
We emphasize that all assays presented hereafter for the analysis of both positive and negative regulators were performed in two independent clonal cell lines for each genotype. In some cases, analysis of only one clonal cell line is shown in the main figure, with data from the second clonal cell line presented in a supplemental figure panel noted in the figure legend.
Tubd1 encodes d-Tubulin, a divergent tubulin conserved across eukaryotes, whose presence in genomes is correlated with the presence of cilia (Figures S3A and S3B) . Mutations in the Chlamydomonas ortholog of Tubd1, encoded by the UNI3 gene, cause defects in the assembly of flagella, which are analogous to vertebrate motile cilia (Dutcher and Trabuco, 1998) . Centrioles in human cells lacking TUBD1 are unstable and fail to undergo maturation (Wang et al., 2017) . GLI1 induction was abolished in Tubd1 À/À NIH/3T3 cells (Figures 4B and S3E) because nearly 100% of these cells lacked primary cilia ( Figure 4C ). RAB34 is a Golgi-associated small GTPase implicated in regulating the sub-cellular distribution of lysosomes (Wang and Hong, 2002) . RAB34 is confined to metazoans, but it is related to the RAB8 proteins that are widely present across most eukaryotic lineages and involved in ciliogenesis (Figures S3A and S3C) . Interestingly, the genomic region upstream of Rab34 has a functional binding site for GLI proteins and Rab34 was shown to be a Hh target gene in the mouse limb bud (Vokes et al., 2007) . The phenotypes of Rab34 À/À mouse embryos, which include polydactyly and exencephaly, are suggestive of defects in Hh signaling and cilia (Dickinson et al., 2016 Figure S3C ). PDCL, a member of the phosducin-like family of proteins, contains an N-terminal a-helical domain and a C-terminal domain of the thioredoxin superfamily. PDCL positively regulates heterotrimeric G-protein signaling by functioning as a chaperone for the assembly of G-protein bg dimers (Lukov et al., 2005) . In many systems, disruption of the Pdcl gene leads to a decline in Gbg protein levels and failure of G-protein signaling. Phylogenetic analysis of the phosducin-like clade hints at a cilium-associated function for Pdcl, in addition to a role in heterotrimeric G-protein signaling ( Figures S3A and S3D ). SHH was unable to induce the expression of the direct target genes Gli1 or Ptch1 in Pdcl À/À cells, although it could induce a decrease in GLI3R, consistent with low-level Hh signaling (Figures 4B and S3E) . The frequency of primary cilia was modestly reduced in Pdcl À/À cells, without significant change in ciliary length (Figures 4G and S3F) . However, there was a severe defect in SHH-induced accumulation of SMO in the ciliary membrane (Figures 4H and 4I) . We note that PDCL could also influence Hh signaling by impairing the activity of heterotrimeric G proteins, such as the screen hit Ga i3 ( Figure 1B ), that antagonize PKA activity. In conclusion, all three genes that emerged as the top hits among positive regulators of Hh signaling regulate ciliary functions. While further work will be required to elucidate the precise mechanisms, two of these genes, Rab34 and Pdcl, have never been linked to cilia. Their involvement suggests cilium-associated roles for Rab-regulated vesicle trafficking and heterotrimeric G-protein signaling. More generally, our analysis of positive regulators reaffirms the concept that genetic screens based on Hh signaling phenotypes can be used to discover genes that regulate the function of cilia.
Negative Regulators of Hh Signaling Suppress SMO Accumulation in Primary Cilia
We undertook a more in-depth analysis of the signaling attenuators Megf8, Mgrn1, and Atthog, because mutations that increase signaling activity are more likely to be in genes that encode (or directly regulate) core signaling components and less likely to cause non-specific or indirect effects.
Megf8 encodes a single-pass, type I transmembrane (TM) protein containing a short cytoplasmic tail and a large multi-domain extracellular region containing modules associated with cell adhesion (CUB and EGF domains) and binding to sugars (the b-propeller forming kelch repeats) ( Figure S4A ). It is conserved across metazoans and their closest sister group, the choanoflagellates, suggesting an origin pre-dating Hh signaling (Figure S3A) . Mgrn1 (or Rnf156) is conserved throughout eukaryotes, regardless of the presence of Hh signaling or cilia, and encodes a ubiquitin E3-ligase containing a putative substratebinding domain at the N terminus and a RING-finger domain (Figures S3A, S4B, and S4C ).
In contrast with positive regulators, the frequency of primary cilia was unaltered in cells carrying loss-of-function mutations in Megf8, Mgrn1, or Atthog ( Figure S5A ). Consistent with assays based on Gli1 mRNA levels ( Figure 3B) 
Megf8
À/À cells was selectively observed in the population that has traversed the endoplasmic reticulum (ER) (post-ER SMO) and thus migrates more slowly on an SDS-PAGE gel due to changes in glycosylation catalyzed by enzymes found in the Golgi ( Figure 5A ). Biotinylation experiments using a non-cell-permeable probe confirmed that cell-surface levels of SMO were markedly elevated in Atthog À/À and Megf8
Visualization of the sub-cellular localization of SMO by confocal fluorescence microscopy revealed that it accumulated to very high levels in the ciliary membrane of Atthog À/À and
À/À cells, even in the absence of SHH ( Figures 5C, 5D , and S5C). The SMO in cilia could be detected in non-permeabilized cells by an antibody against the extracellular region of SMO, demonstrating that it was localized at the cell surface (Figure S5D Figures 3B-3D ). The function of Mgrn1 may be partially redundant with the vertebrate-specific paralog Rnf157, as proteins encoded by these genes display $50% identity ( Figure S4B ). When SMO ciliary accumulation is accompanied by SMO activation, GLI2 protein levels at the tips of cilia increase, as seen when PTCH1 is inactivated by SHH or genetically disrupted in Ptch1 À/À cells ( Figures S5E and S5F ). GLI2 levels were elevated at the tips of cilia in Atthog À/À and Megf8 À/À cell lines and (even in the absence of SHH) were comparable with levels seen in activated WT cells or Ptch1 À/À cells, supporting the presence of increased SMO activity ( Figures S5E and S5F ). Taken together, data from target gene expression studies and ciliary protein localization studies demonstrated that the loss of Atthog, Megf8, and Mgrn1 led to both constitutive, SHH-independent signaling and potentiation of SHH-driven signaling. The striking increase in ciliary SMO pointed to an effect on SMO itself or a step upstream of SMO in the pathway. Activation of signaling downstream of SMO, for example by the loss of SUFU, does not cause the increased accumulation of SMO in primary cilia ( Figures S6A and S6B ). To conclusively address this point, we treated all three mutant cell lines with the direct SMO antagonist vismodegib. Vismodegib completely abolished signaling, both in the absence and the presence of SHH, proving that these negative regulators function at the level of SMO or a step upstream of SMO, such as SHH reception or PTCH1 function ( Figures 5E, 5F , S6C, and S6D).
These negative regulators are unlikely to regulate ligand reception because signaling is increased in cell lines lacking these proteins even in the complete absence of SHH ( Figure 3B) S6F ). Moreover, PTCH1 was cleared from cilia upon SHH addition, showing that SHH could still bind and downregulate PTCH1 normally in the absence of these genes ( Figure S6F ). Thus, increased SMO activity and SMO ciliary levels cannot be due to the faulty trafficking of PTCH1. Despite normal PTCH1 localization, PTCH1 inhibitory activity toward SMO could be compromised. This scenario is unlikely for two reasons. First, despite the high levels of SMO at cilia in Atthog À/À and
À/À cells, they remained responsive to SHH, suggesting that PTCH1 is still able to partially restrain SMO activity ( Figures  3B-3D) . Second, SMO levels in cilia of Atthog À/À and Megf8 À/À cells were considerably higher than in cilia of Ptch1 À/À cells, implying that the loss of these genes must be performing a role other than just reducing PTCH1 activity ( Figure 5D ). In summary, the three negative regulators that emerged as top hits in our screens converged on the same step in signaling, regulation of SMO ciliary localization or activity, suggesting that they may be involved in a common pathway.
ATTHOG Is a Tetraspan Protein that Regulates SMO Stability
We analyzed the function of Atthog in more detail. ATTHOG is an integral membrane protein that belongs to the large tetraspan superfamily. Based on phylogeny, we found ATTHOG to be nested within the radiation of a clade of tetraspans, which includes the claudin-like proteins, best known as components of inter-cellular tight junctions ( Figure 6A ). Therein ATTHOG is most closely related to three paralogous proteins, including one (TMHS) that has been implicated in human deafness as a key component of the mechanotransduction machinery of cochlear hair cells (Xiong et al., 2012) . Sequence alignments of Atthog orthologs ( Figure S7A ) predict that it has four transmembrane helices without a cleaved signal sequence, a disulfide-linked extracellular domain, and a conserved cysteine in the cytoplasmic tail that is predicted to be palmitoylated (Figure 6B) . We also noted an unusual conservation of charged and polar residues in the TM helices that could form an aqueous channel that allows permeation of a hydrophilic solute or could mediate protein interactions within the plane of the membrane ( Figure 6B ).
The loss of ATTHOG led to an increase in the post-ER, cellsurface pool of SMO ( Figure 5B ). When Atthog À/À cells were rescued by the re-expression of Atthog, steady-state SMO levels were reduced to those seen in WT cells ( Figure 6C ) and SMO was cleared from primary cilia ( Figures 6D and 6E ). ATTHOG itself was localized to the ciliary membrane, plasma membrane, and Golgi ( Figures 6D and S7B) . In control experiments, the loss of ATTHOG did not alter levels of Frizzled receptors ( Figure S7C ), the closest relatives of SMO in the GPCR family, and did not change signaling responses to either WNT or BMP ligands in NIH/3T3 cells ( Figures S7D and S7E ). ATTHOG could function by suppressing the accumulation of SMO at the cell surface or by suppressing the active conformation of SMO. Vismodegib, which shifts the SMO conformational equilibrium toward the inactive state, extinguished signaling in Atthog À/À cells ( Figure 5E ) but failed to reduce SMO levels at Figure S7A for an alignment). Families forming monophyletic clades are highlighted in distinct colors. The evolutionary provenance of each family is indicated below the gene name, with potential losses in nematodes indicated by a red cross. Families with cysteines predicted to be palmitoylated are marked (filled yellow circles). White circles with black outlines on the nodes denote a support of R0.9 using the Shimodaira-Hasegawa test on 1,000 resamples. The position of the computed ancestral sequence for rooting is shown with a red circle.
(B) Predicted topology of the four TM helices of ATTHOG. Highlighted features include the disulfide bridge in the extracellular domain (ECD), polar and charged residues in the TM bundle, and a cysteine in the cytoplasmic tail predicted to be palmitoylated. Clustering of hydrophilic residues within the TM bundle is highlighted with a yellow oval. primary cilia ( Figures 6F and 6G ). In contrast, Vismodegib blocked both signaling and SMO ciliary accumulation in Ptch1 À/À cells ( Figures 6F and 6G) . Thus, SMO accumulated in cilia of Atthog À/À cells regardless of whether it was in an active or inactive conformation, suggesting that ATTHOG primarily influences SMO trafficking rather than SMO activation.
We next sought to understand how ATTHOG reduced the steady-state levels of SMO ( Figure 6C ). While the abundance of SMO mRNA was unaffected by the loss of ATTHOG (data not shown), the stability of post-ER SMO was markedly greater in Atthog À/À cells (t 1/2 = 10 hr) compared with WT cells (t 1/2 = 2 hr) ( Figures 7A and 7B ). In contrast, the half-life (C and D) Experimental scheme used to monitor the degradation of cell-surface SMO. The fraction of biotinylated SMO remaining at various times after cellsurface labeling is plotted in (D) and shown in Figure S7F . (E and F) After labeling cell-surface SMO with a thiol-cleavable biotinylation reagent, internalization was monitored by measuring the amount of biotinylated SMO protected from the cell-impermeable reducing agent glutathione (GSH).
(G and H) After labeling live cells with a primary antibody against the extracellular domain of SMO, its levels at cilia were measured at various times after labeling by staining fixed, non-permeabilized cells with a cognate secondary antibody. The fraction of SMO remaining at primary cilia at various times after labeling is shown in (H). Each data point represents a mean ± SD derived from two independent experiments. (legend continued on next page) of PTCH1 was unchanged (even though the abundance of PTCH1 was higher due to increased transcription driven by constitutive signaling). These data show that ATTHOG likely promotes SMO degradation after its exit from the ER. The post-ER population includes SMO in the plasma membrane or in various intracellular membranes. To analyze the trafficking of SMO present at the cell surface, we selectively labeled this pool using a cell-impermeable biotinylation reagent ( Figure 7C ). The stability of cell-surface SMO was much greater in Atthog À/À cells ( Figures   7D and S7F) , likely because of a defect in SMO internalization ( Figures 7E and 7F) . We conclude that ATTHOG promotes the internalization and subsequent degradation of SMO present at the cell surface. The increased levels of SMO in the ciliary membrane of Atthog À/À cells ( Figure 5C ) are likely to be a consequence of an overall increase in plasma membrane SMO. A microscopy-based assay revealed that the turnover of ciliary SMO was much slower in Atthog À/À cells compared with WT cells (Figures 7G and 7H ).
Loss of ATTHOG Modifies SHH-Guided Neural Patterning
An intensively studied role of Hh signaling in vertebrates is in patterning of the developing spinal cord, where ventral neural identity is determined by a gradient of SHH secreted by the notochord and floor plate (Cohen et al., 2013; Jessell, 2000) (Figure 8A ). This morphogenetic activity of Hh ligands can be recapitulated in spinal cord NPCs. Compared with NIH/3T3 cells, NPCs afford a more physiological readout of Hh signaling strength: the adoption of different cell fates assayed by the expression of TFs that define progenitor identity (Cohen et al., 2013; Gouti et al., 2014) . These TFs can be divided into two groups: class I TFs that are expressed in the absence of SHH (PAX6) and class II TFs driven by increasing concentrations of SHH (low, NKX6.1; medium, OLIG2; and high, NKX2.2). Atthog was expressed in the ventral neural tube of E11.5 mouse embryos, a stage when SHH-induced patterning is operative ( Figure 8B ). Thus, we asked if ATTHOG could modify the important relationship between the SHH concentration and neural differentiation, a quantitative dose-response relationship that is essential to the proper patterning of the neural tube. In WT NPCs, low concentrations of SHH induced the full expression of NKX6.1 and the low-level expression of OLIG2, which depend on low-and medium-strength signaling respectively ( Figure 8C ). However, high concentrations of SHH were required to trigger NKX2.2 and to suppress PAX6. In Atthog À/À cells, however, low concentrations of SHH were sufficient to drive full expression of NKX2.2 and full suppression of PAX6 ( Figure 8C ). Thus, the loss of ATTHOG resulted in altered SHH-guided patterning of NPCs: neural progenitor subtypes specified at low concentrations of SHH changed from predominantly NKX6.1 + p2 progenitors to NKX2.2 + p3 progenitors and OLIG2 + motor neuron progenitors. Importantly, the loss of ATTHOG did not change the expression of SOX2, a marker of neural progenitors, showing that the multi-step process of mESC differentiation into NPCs was not influenced by ATTHOG function ( Figure 8C ). To measure complete SHH dose-response curves in WT and Atthog À/À NPCs, we took advantage of the previously described GLI-Venus and OLIG2-mKate dual-reporter cells ( Figures 3C  and 3D ). The induction of both GLI-Venus and OLIG2-mKate fluorescence was 10-fold more sensitive to SHH in Atthog À/À cells compared with WT cells. The SHH dose-response curve was shifted to the left in Atthog À/À cells, with the EC 50 (the concentration required to attain half-maximal levels of GLI-Venus or OLIG2-mKate fluorescence) of SHH decreasing from $10 nM in WT cells to $1 nM in Atthog À/À cells ( Figures 8D and 8E ). As we found in NIH/3T3 cells, the loss of ATTHOG led to the high-level, constitutive accumulation of SMO in the primary cilia of NPCs, suggesting that the mechanism behind the increase in target cell sensitivity is likely to be similar in both cell types ( Figures  8F and 8G ). In summary, the loss of ATTHOG sensitized both NIH/3T3s and NPCs to Hh ligands, altering both target gene expression and differentiation outcomes.
DISCUSSION
We describe a set of four genome-wide screens that comprehensively identified positive, negative, and attenuating regulators of the Hh pathway. While we only characterized a handful of genes that met extremely stringent selection criteria (Figure S2A) , our screens identified many other genes that have statistically significant, quantitative effects on Hh signaling (Table  S1 ). The dataset generated from these screens will serve as a valuable resource for the discovery of genes relevant both to primary cilia and Hh signaling, and consequently to associated diseases such as ciliopathies and other developmental disorders.
This screening strategy, also used in our previous genetic dissection of the WNT pathway (Lebensohn et al., 2016) , identified all classes of regulators by using a fluorescent transcriptional reporter that provides a continuous readout of Hh signaling strength. This choice should be contrasted with alternative digital selection schemes based on cell viability, colloquially known as ''live/dead'' screens. Reporters with continuous readouts, such as fluorescence intensity, allow full control over the stringency of selection applied to the mutant cell library. This flexibility is particularly important when conducting enhancer or suppressor screens in sensitized backgrounds, a powerful and time-honored genetic strategy to elucidate signaling pathways. Indeed, our screen for genes that enhanced signaling in the presence of a low, sub-saturating dose of SHH ( Figure 1D ) was the most successful in identifying known negative regulators and attenuators compared with screens performed either in the absence of SHH ( Figure 1E ) or in the presence of saturating SHH ( Figure 1C) . Similarly, our previous WNT pathway screens identified the attenuator ZNRF3 only when signaling was activated with low ligand concentrations (Lebensohn et al., 2016) . We propose that varying the ligand concentration provides an easy but powerful method to sensitize screens in cultured cells and thereby reveal hidden layers of regulation that tune signaling strength. This may be particularly relevant for graded signaling pathways initiated by morphogens such as WNT and Hh that can engage distinct differentiation programs at varying concentrations. The screening platform described here should be broadly applicable to uncover genes regulating any cellular process that can be monitored using a fluorescence-based reporter that allows for FACS-based enrichment of cells with the desired phenotype. In addition to the identification of most components of the Hh pathway and the identification of many genes involved in cilia and ciliopathies, our genetic analysis uncovered a hidden layer of regulation in vertebrate Hh signaling. Three of the top signaling attenuators, Megf8, Mgrn1, and Atthog, all suppressed SMO protein levels at the cell surface and cilium, likely by regulating its endocytosis from the plasma membrane. The loss of these genes led to a $10-fold increase in sensitivity to SHH and, consequently, alterations in SHH-induced NPC differentiation outcomes. The most straightforward explanation for this potentiation effect is that high ciliary SMO protein levels overwhelm the inhibitory capacity of PTCH1.
While Atthog was a formerly uncharacterized gene, both Megf8 and Mgrn1 have been studied previously and phenotypes of animals carrying mutations in these genes have been reported (Cota et al., 2006; Engelhard et al., 2013; He et al., 2003; Phan et al., 2002; Zhang et al., 2009) . Does this prior analysis support a role for these genes in the Hh pathway as suggested by our screens? Forward genetic screens in mice demonstrated that Megf8 mutations cause embryonic lethality with multi-organ defects (Engelhard et al., 2013; Zhang et al., 2009) . Megf8 was proposed to be a modifier of BMP signaling due to phenotypic similarities with BMP loss-of-function mice, but this correlation was not tested using direct signaling assays (Engelhard et al., 2013) . Many phenotypes seen in Megf8 À/À mice, such as polydactyly, cardiac development defects, exencephaly, and heterotaxy, are also associated with Hh signaling defects. Human genetics supports a role of MEGF8 as a Hh pathway modifier. Mutations in MEGF8 cause a subtype of Carpenter's syndrome associated with heterotaxy, congenital cardiac defects, pre-axial polydactyly, and skeletal and craniofacial defects (Twigg et al., 2012) . Some of the skeletal phenotypes seen in these patients, such as hypertelorism and polydactyly, are associated with increased Hh signaling. Strikingly, most individuals with Carpenter's syndrome have mutations in RAB23 (Jenkins et al., 2007) , which encodes a previously described negative regulator of Hh signaling that was also identified as a top hit in our LoSHH_Top5% screen ( Figure 1D ; Eggenschwiler et al., 2001) . Thus, consistent with our results, the loss of MEGF8 resembles the loss of other known negative regulators of the Hh pathway in both mice and humans.
Mice carrying mutations in Mgrn1 display pigmentation defects and progressive spongiform degeneration, phenotypes not typically associated with Hh signaling (He et al., 2003; Phan et al., 2002) . However, Mgrn1 À/À embryos have a 40%-60% incidence of embryonic lethality, which has only been partially characterized. A subset of these embryos ($25%) display heterotaxy and complex cardiac anomalies, phenotypes that overlap with Megf8 À/À mice (Cota et al., 2006) . Both phenotypes can be associated with impaired ciliary function or Hh signaling. The lack of a strong embryonic Hh phenotype in these mice may be because Mgrn1 is redundant with Rnf157 in vertebrates ( Figure S4B ). The common influence on SMO stability and the common signaling phenotype points to the possibility that Megf8, Mgrn1, and Atthog function in the same pathway. In fact, MGRN1 and MEGF8 are annotated as interaction partners in the high-quality BioPlex protein interaction database (http:// bioplex.hms.harvard.edu/). MGRN1 has been shown to function with ATTRACTIN (ATRN), a paralog of MEGF8, to downregulate the MC4R melanocortin receptor (Overton and Leibel, 2011) . Loss-of-function mutations in either Mgrn1 or Atrn lead to elevated cell-surface levels of MC4R, analogous to our observation that disruption of Mgrn1 or Megf8 lead to increased cell-surface and ciliary levels of SMO. Hence, the common biochemical function of MEGF8, ATRN, and other related proteins may be to target selected GPCRs for ubiquitination and downregulation by MGRN1 and related RING-finger cytoplasmic E3 ligases.
We end by noting that the post-translational mechanism of SMO regulation uncovered by our screens is conceptually analogous to the intensively studied mechanism that attenuates WNT signaling by decreasing the cell-surface levels of Frizzled (FZD) proteins, receptors for WNT ligands that are the closest relatives of SMO in the GPCR superfamily. In vertebrates, two transmembrane E3 ubiquitin ligases, ZNRF3 and RNF43, dampen sensitivity to WNT ligands by reducing cell-surface levels of FZD receptors (reviewed in de Lau et al., 2014) . Ligands of the R-Spondin family bind and neutralize ZNRF3/RNF43 with the assistance of LGR co-receptors, allowing FZD levels and WNT sensitivity to dramatically increase in specific tissues during development and in specific stem cell compartments in adults. Future work will investigate whether Megf8, Mgrn1, or Atthog are regulated either by Hh ligands themselves or by other signals to potentiate or attenuate Hh signaling.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Culture Flp-In-3T3 (a derivative of NIH/3T3 cells) and 293FT cell lines were purchased from Thermo Fisher Scientific and used without further authentication. Information on the gender of cell lines is not available. A Flp-In-3T3 stable cell line expressing tagged Atthog was generated as previously described (Pusapati et al., 2014) . NIH/3T3 cells expressing GLI-GFP and Cas9 were generated by transduction of the previously described NIH/3T3-GLI-GFP line (Phua et al., 2017) with lentiCas9-Blast (Addgene #52962; ), followed by selection with Blasticidin (2 mg/ml). Single cells were sorted using FACSAria II (BD) and multiple clones were analyzed for optimal Cas9 expression and SHH induced GFP reporter fluorescence. A clonal cell line (NIH3T3-CG) that displayed robust on-target genome editing activity with multiple positive control sgRNAs and also displayed the widest dynamic range for SHH-induced GFP reporter fluorescence was chosen for further studies ( Figure S1 ). All the above mentioned cell lines were cultured in Dulbecco's Modified Eagle Medium (DMEM) containing high glucose (Thermo Scientific) and supplemented with 10% fetal bovine serum (FBS) (Atlanta Biologicals), 1 mM sodium pyruvate (Gibco), 2 mM L-Glutamine (Gemini Biosciences), 1x MEM non-essential amino acids solution (Gibco), penicillin (40 U/ml) and streptomycin (40 mg/ml) (Gemini Biosciences), in a humidified atmosphere containing 5% CO 2 at 37 C. Maintenance of mESCs and their differentiation into NPCs is described below. Stocks of cell lines and derivatives were free of mycoplasma contamination.
To initiate Hh signaling, NIH/3T3 cells were first ciliated by growth to confluence in DMEM containing 10% FBS followed by serum starvation in DMEM containing 0.5% FBS for 24 h. A detailed description of all treatment protocols are included in the ''Ligand and small molecule inhibitor treatment protocols'' section.
Neural Progenitor Differentiation Assays
The construction and use of the HM1 mESC line harboring the GLI-Venus and OLIG2-mKate dual reporter system to evaluate Hh signaling has been described previously in detail (doi: https://doi.org/10.1101/104307) (Gouti et al., 2014) . The parental HM1 mESC line is derived from a male mouse. For mESC maintenance, feeders were plated onto dishes coated with 0.1% gelatin (Sigma-Aldrich) overnight. ESCs were cultured with feeders in mESC media (DMEM containing high glucose, 15% Optima FBS (Atlanta Biologicals), 1x MEM non-essential amino acids, 1% penicillin/streptomycin, 2 mM L-glutamine, 1% EmbryoMax nucleosides (Millipore), 55 mM 2-mercaptoethanol (Gibco), and 1000 U/ml ESGRO LIF (Millipore)). mESCs were differentiated into spinal neural progenitors using a previously described protocol with minor modifications (Gouti et al., 2014) . Briefly, mESCs were cleared from feeder cells and plated onto either gelatin coated glass coverslips (12mm diameter, placed in a 24-well plate) at a density of 50,000 cells/coverslip (immunofluorescence staining) or onto gelatin coated CellBIND plates (Corning) at a density of 100,000 cells/6-well (FACS) or 500,000 cells/10 cm plate (Western Blotting). Differentiations were conducted in N2B27 media (Dulbecco's Modified Eagle's Medium F12 (Gibco) and Neurobasal Medium (Gibco) (1:1 ratio) supplemented with N-2 Supplement (Gibco), B-27 Supplement (Gibco), 1% penicillin/streptomycin (Gemini Bio-Products), 2mM L-glutamine (Gemini Bio-Products), 40 mg/ml Bovine Serum Albumin (Sigma), and 55 mM 2-mercaptoethanol (Gibco)). On the day the cells were plated (Day 0) and Day 1, the N2B27 medium was supplemented with 10 ng/ml bFGF (R&D). On Day 2, 10 ng/ml bFGF (R&D) and 5 mM CHIR99021 (Axon) were added to the N2B27 culture medium. On Day 3, cells were cultured in N2B27 medium containing RA (100 nM, Sigma-Aldrich) or RA with different doses of SHH. A fresh medium change with the same ingredients was done on Day 4 and Day 5. On Day 6, cells were rinsed with PBS and either fixed with 4% PFA (immunofluorescence staining), trypsinized (FACS analysis), or lysed for Western Blot analysis.
METHOD DETAILS Constructs
Mouse Atthog was tagged with a C-terminal 1D4 and cloned into pEF5/FRT/V5-DEST vector (Thermo Fisher Scientific).
Reagents and Antibodies
Recombinant SHH was expressed in bacteria and purified as previously described (Bishop et al., 2009) . Recombinant WNT3A and BMP4 were purchased from R&D Systems and Thermo Fisher Scientific, respectively. Leupeptin, puromycin, blasticidin, and polybrene were purchased from Sigma-Aldrich. Vismodegib and Bafilomycin A1 were purchased from LC Labs. The following primary antibodies were used: mouse anti-GLI1 (2643; Cell Signaling; 1:1000), goat anti-GLI3 (AF3690; R&D; 1:200), rabbit anti-p38 (ab7952; Abcam; 1:2000), mouse anti-1D4 (The University of British Columbia; 1:5000), mouse a-Tubulin (T6199; Sigma-Aldrich; 1:10000), mouse acetylated-Tubulin (T6793; Sigma-Aldrich; 1:10000), mouse anti-NKX6.1 (F55A10, Developmental Studies Hybridoma Bank; 1:100), mouse anti-NKX2.2 (74.5A5, Developmental Studies Hybridoma Bank; 1:100), rabbit anti-PAX6 (AB2237; EMD Millipore; 1:1000), and Alexa Fluor 488 conjugated anti-Giantin (A488-114L; Covance; 1:500). Polyclonal antibodies against PTCH1, SMO (against both intracellular and extracellular epitopes (Milenkovic et al., 2009; Rohatgi et al., 2007) ), SUFU (Humke et al., 2010) , IQCE (Pusapati et al., 2014) , GLI2 (Niewiadomski et al., 2014) , ARL13B (Dorn et al., 2012) , and OLIG2 (Novitch et al., 2003) have been described previously. Secondary antibodies conjugated to horseradish peroxidase or Alexa Fluor dyes were obtained from Jackson Laboratories and Thermo Fisher Scientific.
Ligand and Small Molecule Inhibitor Treatment Protocols
Throughout the text, the terms NoSHH, LoSHH, and HiSHH refer, respectively, to treatment with no SHH, a low, sub-saturating concentration of SHH, or a high, near-saturating concentration of SHH (see Figure S1B for the position of the LoSHH and HiSHH concentrations on the dose-response curve). For the directed experiments in NIH/3T3 cells, LoSHH and HiSHH concentrations used were 1 nM and 25 nM. For the genome-wide screens, LoSHH and HiSHH concentrations used were 3.2 nM and 25 nM. For NPCs, the LoSHH and HiSHH concentrations used were 5 nM and 25 nM. NIH/3T3 cells were treated with SHH for either 24 hours (CRISPR screens, qRT-PCR, immunoblotting, cycloheximide chase assay, SMO degradation, and internalization assays) or 6 hours (immunofluorescence studies). For NPCs, the duration of SHH exposure was 72 hours for all assays. Vismodegib was used at 1 mM. WNT3A was used at 200 ng/ml for 9 h and BMP4 was used at 50 ng/ml for 5 h.
Pooled Genome-wide CRISPR/Cas9 Screens Our screen design was influenced by the lessons learned during our work on dissecting the WNT pathway using genetic screens in human haploid cells (Lebensohn et al., 2016) . Since haploid cells lack primary cilia and so cannot transduce Hh signals, we used NIH/ 3T3 cells, mouse embryonic fibroblasts that are characterized by a robust transcriptional response to SHH. To isolate mutant cells with the desired Hh signaling phenotype, we used a fluorescence-based, quantitative transcriptional reporter of Hh signaling, which allowed the use of FACS to enrich cells with enhanced or reduced signaling phenotypes. The concentration-dependent properties of Hh ligands during development motivated us to perform screens at different concentrations of SHH. The Brie CRISPR library (Addgene #73633 (Doench et al., 2016) ) was used to generate our genome-wide collection of mutant NIH/3T3 cells because this moderately sized library, which targets each of 19,674 mouse genes with $4 short guide RNAs (sgRNAs) and includes 1000 non-targeting
Real-Time Quantitative Reverse Transcription PCR (Real-Time qRT-PCR)
Real-Time qRT-PCR was performed using the Power SYBR Green Cells-to-CT Kit (Thermo Fisher Scientific) on a QuantStudio 5 Real-Time PCR System (Thermo Fisher Scientific) with custom designed primers for Gli1 (Fwd: 5'-ccaagccaactttatgtcaggg-3' and Rev: 5'-agcccgcttctttgttaatttga-3'), Axin2 (Fwd: 5'-aaacggattcaggtccttca-3' and Rev: 5'-caaagacatagccggaacct-3'), Id1 (Fwd: 5'-aacggcgagatcagtgcctt-3' and Rev:5'-cctcagcgacacaagatgcgat-3'), and Gapdh (Fwd: 5'-agtggcaaagtggagatt-3' and Rev: 5'-gtggagtcatactggaaca-3'). Transcript levels relative to gapdh were calculated using the DCt method.
Western Blotting
Whole cell extracts from NIH/3T3 cells and NPCs were prepared in RIPA lysis buffer (50 mM Tris-HCl pH-7.4, 150 mM NaCl, 2% NP-40, 0.25% Deoxycholate, 0.1% SDS, 1mM DTT, 10% glycerol, 1x SIGMAFAST protease inhibitor cocktail (Sigma-Aldrich), and 1x PhosSTOP (Roche)). Samples were resuspended in NuPAGE-LDS sample buffer (Thermo Fisher Scientific), incubated at 37 C for 30 min, and subjected to SDS-PAGE. The resolved proteins were transferred onto a nitrocellulose membrane (Bio-Rad) using a wet electroblotting system (Bio-Rad) followed by immunoblotting.
SMO Trafficking Assays
Biotinylation of cell surface SMO with a non-cell permeable, thiol-cleavable probe was performed as described previously (Milenkovic et al., 2009 ). Briefly, cell culture plates were removed from the 37 C incubator and placed on an ice-chilled metal rack in a 4 C cold room. Growth medium was removed and cells were quickly washed thrice with ice-cold DPBS+ buffer (Dulbecco's PBS supplemented with 0.9 mM CaCl 2 , 0.49 mM MgCl 2 .6H 2 O, 5.6 mM dextrose, and 0.3 mM sodium pyruvate). Cells were incubated with a freshly prepared solution of 0.4 mM Sulfo-NHS-SS-Biotin (Thermo Fisher Scientific) in DPBS+ buffer for 30 min. Unreacted Sulfo-NHS-SS-Biotin was quenched with Tris pH 7.4 at 50 mM for 10 min. Cells were then washed thrice with 1x Tris-buffered saline (25 mM Tris-HCl pH 7.4, 137 mM NaCl, and 2.7 mM KCl) and whole cell extracts were prepared in a buffer containing 50 mM Tris-HCl pH-7.4, 150 mM NaCl, 2% NP-40, 0.25% Deoxycholate, 1x Sigma-Fast protease inhibitor cocktail, and 1x Roche phosphatase inhibitor cocktail. Biotinylated proteins from clarified supernatants were captured on a streptavidin agarose resin (Solulink), washed, eluted in NuPAGE-LDS sample buffer containing 100 mM DTT at 37 C for 1 h to cleave and release biotinylated proteins, and assayed by immunoblotting. For degradation assays (shown in Figures 7C and 7D ), cells were transferred to a 37 C incubator after cell-surface biotinylation and samples were harvested in a 4 C cold room after 0, 0.5, 1, 2, 3, 4, 5, and 6 h. For internalization assays (shown in Figures 7E and 7F ), cells were pre-treated with 100 nM Bafilomycin A1 and 50 mM Leupeptin for 2 h to block lysosomal degradation. Cell-surface proteins were biotinylated as described above (with the exception that Bafilomycin A1 and Leupeptin were included at every step) and then transferred to a 37 C incubator for 0, 5, 10, and 20 minutes before being returned to 4 C. To estimate the amount of biotinylated SMO that was internalized during the 37 C incubation period, cells were treated twice with glutathione (50 mM glutathione, 75 mM NaCl, 75 mM NaOH, and 10% FBS in water) at 4 C for 15 min to cleave the biotin attached to any SMO left on the cell surface. Any biotinylated SMO that was internalized would be protected from glutathione cleavage. After quenching unreacted glutathione with iodoacetamide buffer (50 mM iodoacetamide and 1% BSA in D-PBS+ buffer) at 4 C for 20 min, cells were lysed (in the continued presence of 50 mM iodoacetamide) and the amount of biotinylated SMO remaining was assessed by streptavidin pull down followed by immunoblotting.
In Situ Hybridization
Atthog specific primers were designed using the program Primer3 (Fwd: 5'-acacgtgtgtgctgaaaagc-3' and Rev: 5'-gagattaaccctcac taaagggatgagcaggtaacccatctcc-3').' The underlined sequence marks the T3 polymerase binding site incorporated into the reverse primer. The Atthog probe was generated using a Digoxigenin (DIG) RNA Labeling Kit (Roche). Briefly, the probe was generated from the in vitro transcription of PCR products amplified from mouse neural progenitor cell cDNA. After overnight hybridization at 70 C, the signal was visualized using anti-DIG-alkaline phosphatase (AP) Fab fragments (Roche) and NBT/BCIP (Roche).
Analysis of Cilia Protein Localization by Immunofluorescence
Immunofluorescence staining of 1D4 tagged ATTHOG, endogenous SMO, PTCH1, GLI2, acTub, and ARL13B was performed as described previously (Pusapati et al., 2014) . Staining of cell-surface SMO using an antibody against its extracellular domain (Milenkovic et al., 2009) was performed by excluding detergent from the blocking and antibody incubation steps. For cilia internalization assays (shown in Figures 7G and 7H ), cell-surface SMO was labeled with the anti-SMO primary antibody at 4 C. Cells were then transferred to 37 C to allow trafficking for 0.25, 0.45, 1.5, 2, 3, and 4 h, followed by immediate fixation with 4% PFA and subsequent staining with a secondary antibody without cell permeabilization to only detect cell-surface SMO. After a second fixation step and washing, cells were permeabilized, stained with a cilia marker and imaged to quantify levels of SMO at primary cilia (see below for quantification details). Fluorescent images were collected on a Leica TCS SP5 confocal imaging system equipped with a 63x oil immersion objective with identical gain, offset, and laser power settings. Z-stacks covering 4 microns were captured and a max-projection of the z-stack was used for fluorescent intensity quantifications. Representative images were captured on the 63x oil objective with an 8x digital zoom option and processed with identical settings using Fiji (Schindelin et al., 2012) (https://fiji.sc).
For quantification of ciliary SMO and PTCH1 levels, Leica Image Files (LIF) were converted into matrices in MATLAB R2014a (MathWorks) using the bfmatlab toolbox. A max-z-projection was performed for each set of planes in a given field, followed by quantification of the cilia and protein-of-interest through the following steps. First, a two-dimensional median filter was applied to the cilia
QUANTIFICATION AND STATISTICAL ANALYSIS
All four screens ( Figures 1B-1E ) were performed twice under independent conditions and the duplicates from each screen were analyzed together using the MAGeCK tool. For Phase I of the validation (Figure S2A ), two cell lines expressing different sgRNAs against each candidate gene were generated. Cell lines expressing short guides against putative positive regulators ( Figure S2B ) were analyzed three independent times and cell lines expressing short guides against putative negative regulators ( Figures  S2C-S2E ) were analyzed two independent times. Within each of these independent experiments, each measurement represents median fluorescence from $10,000 cells analyzed by FACS.
For Phase II of the validation (Figure 3 ), 2-3 independent clonal cell lines (represented by circles, triangles or squares in the Figure 3 ) were isolated for each genotype and the mean Gli1 mRNA levels ( Figures 3A and 3B ) or median reporter fluorescence ( Figures 3C and  3D ) across these independent clonal cell lines was averaged and depicted as bars. For each cell line, the Gli1 mRNA levels were taken as the average from two technical duplicates and the average median reporter fluorescence ($10,000 cells) from two independent experiments. Thus, Phase II of validation was scored based on reproducibility across multiple, independent clonal cell lines, not just across biological or technical replicates in the same cell line.
All the cell biological and biochemical experiments shown in Figures 4, 5, 6 , 7, and 8 to characterize each of the six genes that emerged from Phase II of the validation were performed at least twice in each of two independent clonal cell lines, with similar results. Space permitting, data from two clonal cell lines is shown together. In some cases, analysis of only one clonal cell line is shown in the main figure, with data from the second clonal cell line presented in a supplemental figure panel noted in the figure legend. A phenotype is discussed in the text only if it was observed in both clonal lines.
The statistical significance between two groups was determined by an unpaired Student's t-test (Hh FACS reporter assays and qRT-PCR data). The statistical significance of fluorescent intensity comparisons between two or multiple groups was determined by Mann-Whitney and Kruskal-Wallis non-parametric ANOVA tests, respectively.
DATA AND SOFTWARE AVAILABILITY
All Fastq files from NGS have been deposited into the NIH Short Read Archive (SRA) with Study accession number SRP116669. The scripts used for cilia imaging are publicly available at Github (https://github.com/heybhaven/Cilia_protein_quantification).
